These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20251034)
1. The use of X-ray therapy for retinal diseases characterized by new-formed blood vessels (Eales' disease, retinitis proliferans), a preliminary report. GUYTON JS; REESE AB Trans Am Acad Ophthalmol Otolaryngol; 1947; 51():525-46. PubMed ID: 20251034 [No Abstract] [Full Text] [Related]
2. Use of roentgen therapy for retinal diseases characterized by new-formed blood vessels; Eale's disease; retinitis proliferans. GUYTON JS; REESE AB Arch Ophthal; 1948 Oct; 40(4):389-412. PubMed ID: 18123286 [No Abstract] [Full Text] [Related]
3. The treatment of Eales' disease by roentgen therapy. REESE AB; JONES IS Am J Ophthalmol; 1960 Jun; 49():1311-4. PubMed ID: 14436913 [No Abstract] [Full Text] [Related]
4. Eales' disease: accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage. Bhooma V; Sulochana KN; Biswas J; Ramakrishnan S Curr Eye Res; 1997 Feb; 16(2):91-5. PubMed ID: 9068938 [TBL] [Abstract][Full Text] [Related]
5. Preliminary report on diathermic coagulation of diseased vessels in Eales' disease; results obtained since 1939 in the Ned. Gasthuis voor Ooglijders at Utrecht. DONDERS PC Ophthalmologica; 1956 Nov; 132(5):334-7. PubMed ID: 13388272 [No Abstract] [Full Text] [Related]
7. Roentgen therapy of Eales' disease; the value of treatment as judged by late results. ANJOU I; CEDERQUIST E Acta Ophthalmol (Copenh); 1957; 35(5):441-50. PubMed ID: 13497643 [No Abstract] [Full Text] [Related]
9. Elevated tumor necrosis factor in serum is associated with increased retinal ischemia in proliferative eales' disease. Saxena S; Khanna VK; Pant AB; Meyer CH; Singh VK Pathobiology; 2011; 78(5):261-5. PubMed ID: 21849807 [TBL] [Abstract][Full Text] [Related]
10. Retinal haemorrhage with vitreous clouding in young adults (Eales' disease). O'MALLEY CL Trans Ophthalmol Soc U K; 1944-1945; 64():261-9. PubMed ID: 21024434 [No Abstract] [Full Text] [Related]
11. Some recent studies on Eales' disease. WAGENER HP Am J Med Sci; 1958 Aug; 236(2):250-63. PubMed ID: 13559241 [No Abstract] [Full Text] [Related]
12. Eales' disease with neurological complications. Anand SS; Das G; Chakraborty DP; Saha SP; Bose B Neurol India; 2013; 61(4):428-9. PubMed ID: 24005742 [No Abstract] [Full Text] [Related]
13. Treatment of Eales' disease: diathermy coagulation. MERZ EH; HAUSER P Am J Ophthalmol; 1957 Jun; 43(6):882-4. PubMed ID: 13424611 [No Abstract] [Full Text] [Related]
14. Recurrent intraocular hemorrhage in young adults (Eales' disease); treatment with continuous subconjunctival therapy with hydrocortisone. ELLIOT AJ AMA Arch Ophthalmol; 1959 May; 61(5):745-54. PubMed ID: 13636570 [No Abstract] [Full Text] [Related]
15. [Surgical treatment of recurrent retinovitreous hemorrhage in young subjects (Eales' disease)]. FRANCESCHETTI A; FORNI S Ophthalmologica; 1954; 127(4-5):339-41. PubMed ID: 13176935 [No Abstract] [Full Text] [Related]
16. Visualization of retinal vasculitis in Eales' disease. Atmaca LS; Idil A; Gündüz K Ocul Immunol Inflamm; 1993; 1(1-2):41-8. PubMed ID: 22827191 [TBL] [Abstract][Full Text] [Related]
17. Eales' disease treated with cortisone, streptomycin and vitamin C. MAHON D J Ir Med Assoc; 1951 Mar; 28(165):50-1. PubMed ID: 14824636 [No Abstract] [Full Text] [Related]
18. Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease. Rajesh M; Sulochana KN; Coral K; Punitham R; Biswas J; Babu K; Ramakrishnan S Indian J Ophthalmol; 2004 Jun; 52(2):139-44. PubMed ID: 15283219 [TBL] [Abstract][Full Text] [Related]